Home Healthcare Pharmaceuticals Apixaban Market

Apixaban Market Size, Share & Trends Analysis Report By Dosage Strength (2.5 mg, 5 mg), By Indication (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Post-Operative Venous Thromboembolism Prophylaxis), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 13, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. North America Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  8. Europe Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. France
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  9. APAC Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. China
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. India
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  11. LATAM Apixaban Market Size Analysis
    1. Introduction
    2. Apixaban Market Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
      1. 2.5 mg
      2. 5 mg
    3. Apixaban Market Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
      1. Atrial Fibrillation
      2. Deep Vein Thrombosis
      3. Pulmonary Embolism
      4. Post-Operative Venous Thromboembolism Prophylaxis
    4. Apixaban Market Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Dosage Strength 2025-2034 (USD MILLION/ Units)
        1. 2.5 mg
        2. 5 mg
      3. Market Size & Forecast By Indication 2025-2034 (USD MILLION/ Units)
        1. Atrial Fibrillation
        2. Deep Vein Thrombosis
        3. Pulmonary Embolism
        4. Post-Operative Venous Thromboembolism Prophylaxis
      4. Market Size & Forecast By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Apixaban Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Bristol-Myers Squibb Company (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc. (US)
    3. Viatris Inc. (US)
    4. Centaur Pharmaceuticals Pvt. Ltd. (India)
    5. Sandoz Group AG (Switzerland)
    6. Sun Pharmaceutical Industries Ltd. (India)
    7. Aurobindo Pharma Limited (India)
    8. Dr. Reddy’s Laboratories Ltd. (India)
    9. Cipla Limited (India)
    10. Glenmark Pharmaceuticals Ltd. (India)
    11. Medichem S.A. (Spain)
    12. Simson Pharma Limited (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer

List of Tables

Table 1: Global Apixaban Market Size and Forecast By Regions - 2022-2034 (USD USD Billion)

Table 2: Global Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 3: Global Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 4: Global Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 5: North America Apixaban Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 6: North America Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 7: North America Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 8: North America Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 9: U.S. Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 10: U.S. Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 11: U.S. Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 12: Canada Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 13: Canada Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 14: Canada Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 15: Europe Apixaban Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 16: Europe Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 17: Europe Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 18: Europe Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 19: U.K. Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 20: U.K. Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 21: U.K. Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 22: Germany Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 23: Germany Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 24: Germany Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 25: France Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 26: France Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 27: France Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 28: Spain Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 29: Spain Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 30: Spain Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 31: Italy Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 32: Italy Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 33: Italy Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 34: Russia Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 35: Russia Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 36: Russia Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 37: Nordic Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 38: Nordic Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 39: Nordic Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 40: Benelux Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 41: Benelux Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 42: Benelux Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 43: Rest of Europe Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 44: Rest of Europe Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 45: Rest of Europe Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 46: APAC Apixaban Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 47: APAC Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 48: APAC Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 49: APAC Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 50: China Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 51: China Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 52: China Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 53: Korea Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 54: Korea Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 55: Korea Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 56: Japan Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 57: Japan Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 58: Japan Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 59: India Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 60: India Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 61: India Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 62: Australia Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 63: Australia Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 64: Australia Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 65: Taiwan Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 66: Taiwan Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 67: Taiwan Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 68: South East Asia Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 69: South East Asia Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 70: South East Asia Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 71: Rest of Asia-Pacific Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 72: Rest of Asia-Pacific Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 73: Rest of Asia-Pacific Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 74: Middle East and Africa Apixaban Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 75: Middle East and Africa Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 76: Middle East and Africa Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 77: Middle East and Africa Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 78: UAE Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 79: UAE Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 80: UAE Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 81: Turkey Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 82: Turkey Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 83: Turkey Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 84: Saudi Arabia Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 85: Saudi Arabia Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 86: Saudi Arabia Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 87: South Africa Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 88: South Africa Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 89: South Africa Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 90: Egypt Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 91: Egypt Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 92: Egypt Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 93: Nigeria Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 94: Nigeria Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 95: Nigeria Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 96: Rest of MEA Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 97: Rest of MEA Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 98: Rest of MEA Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 99: LATAM Apixaban Market Size and Forecast By Country - 2022-2034 (USD USD Billion)

Table 100: LATAM Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 101: LATAM Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 102: LATAM Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 103: Brazil Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 104: Brazil Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 105: Brazil Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 106: Mexico Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 107: Mexico Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 108: Mexico Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 109: Argentina Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 110: Argentina Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 111: Argentina Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 112: Chile Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 113: Chile Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 114: Chile Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 115: Colombia Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 116: Colombia Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 117: Colombia Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Table 118: Rest of LATAM Apixaban Market Size and Forecast By Dosage Strength - 2022-2034 (USD USD Billion)

Table 119: Rest of LATAM Apixaban Market Size and Forecast By Indication - 2022-2034 (USD USD Billion)

Table 120: Rest of LATAM Apixaban Market Size and Forecast By Distribution Channel - 2022-2034 (USD USD Billion)

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.